Domov › Akútna myeloidná leukémia › Michigan › Ann Arbor
Klinické štúdie Akútna myeloidná leukémia v meste Ann Arbor, MI
17 štúdií pre Akútna myeloidná leukémia hľadá účastníkov v zariadeniach v meste Ann Arbor a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 míľ odtiaľ
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Prebieha náborFáza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- a 1 ďalších
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
Prebieha náborFáza 1
- C S Mott Children's Hospital, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- a 4 ďalších
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 míľ odtiaľ
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Prebieha náborFáza 3
- Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 míľ odtiaľ
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- a 1 ďalších
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Prebieha náborFáza 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 míľ odtiaľ
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 míľ odtiaľ
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Prebieha náborFáza 3
- C S Mott Children's Hospital, Ann Arbor
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Prebieha náborFáza 3
- C S Mott Children's Hospital, Ann Arbor
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Prebieha náborFáza 1/2
- C S Mott Children's Hospital, Ann Arbor
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Prebieha náborFáza 3
- C.S. Mott Children's Hospital, Ann Arbor
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Prebieha náborFáza 3
- University of Michigan, Ann Arbor
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Prebieha náborObservačná štúdia
- University of Michigan, Ann Arbor
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Prebieha náborFáza 1
- University of Michigan, Ann Arbor
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Prebieha náborFáza 1
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Štúdie Akútna myeloidná leukémia v iných mestách
- Houston, TX85 štúdií
- New York City, NY51 štúdií
- Boston, MA44 štúdií
- Seattle, WA41 štúdií
- Baldwin Park, CA40 štúdií
- Columbus, OH35 štúdií
- Philadelphia, PA34 štúdií
- Durham, NC33 štúdií
- Atlanta, GA31 štúdií
- Tampa, FL29 štúdií
- Chicago, IL26 štúdií
- Portland, OR25 štúdií
Iné štúdie v Ann Arbor
- Rakovina prsníka27 štúdií
- Rakovina prostaty27 štúdií
- Nemalobunkový karcinóm pľúc26 štúdií
- Rakovina (všetky typy)25 štúdií
- Rakovina pľúc23 štúdií
- Kolorektálny karcinóm23 štúdií
- Srdcové zlyhanie22 štúdií
- Kardiovaskulárne ochorenia16 štúdií
- Rakovina pankreasu14 štúdií
- Melanóm12 štúdií
- Cievna mozgová príhoda12 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku12 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.